Evidence map›Paper›PMID 33184588›Full record

ReviewRSC advances2020

Enabling protein-hosted organocatalytic transformations.

Alexander R Nödling, Nicolò Santi, Thomas L Williams, Yu-Hsuan Tsai, Louis Y P Luk

Open access · goldAbstract readReview
In one paragraph

Review in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Exploring PadR Proteins for Artificial Enzyme Design.Chembiochem : a European journal of chemical biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Streptavidin-Hosted Organocatalytic Aldol Addition.Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexander R NödlingSchool of Chemistry, Cardiff University, Main Building, Cardiff, CF10 3AT, UK. Email: lukly@cardiff.ac.uk.ORCID 0000-0002-3483-6266
Nicolò SantiSchool of Chemistry, Cardiff University, Main Building, Cardiff, CF10 3AT, UK. Email: lukly@cardiff.ac.uk.ORCID 0000-0001-6361-5457
Thomas L WilliamsSchool of Chemistry, Cardiff University, Main Building, Cardiff, CF10 3AT, UK. Email: lukly@cardiff.ac.uk.
Yu-Hsuan TsaiSchool of Chemistry, Cardiff University, Main Building, Cardiff, CF10 3AT, UK. Email: lukly@cardiff.ac.uk.ORCID 0000-0003-0589-5088
Louis Y P LukSchool of Chemistry, Cardiff University, Main Building, Cardiff, CF10 3AT, UK. Email: lukly@cardiff.ac.uk.ORCID 0000-0002-7864-6261
Cardiff University · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

In this review, the development of organocatalytic artificial enzymes will be discussed. This area of protein engineering research has underlying importance, as it enhances the biocompatibility of organocatalysis for applications in chemical and synthetic biology research whilst expanding the catalytic repertoire of enzymes. The approaches towards the preparation of organocatalytic artificial enzymes, techniques used to improve their performance (selectivity and reactivity) as well as examples of their applications are presented. Challenges and opportunities are also discussed.

Identifiers

PMID33184588
PMCPMC7654312
OpenAlexW3018668257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.